859 related articles for article (PubMed ID: 12124405)
41. The long-term course of chronic hepatitis B.
Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
[TBL] [Abstract][Full Text] [Related]
42. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
43. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
44. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years.
Kondili LA; Cuko L; Chionne P; Candido A; Madonna E; Dentico P; Resuli B; Taliani G; Brunetto MR; Rapicetta M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):167-71. PubMed ID: 19734797
[TBL] [Abstract][Full Text] [Related]
46. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
48. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
Yu MW; Hsieh HH; Pan WH; Yang CS; CHen CJ
Cancer Res; 1995 Mar; 55(6):1301-5. PubMed ID: 7882326
[TBL] [Abstract][Full Text] [Related]
49. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
50. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Batrla-Utermann R; Wang LY; You SL; Hsiao CK; Chen PJ; Chen CJ;
Gut; 2014 Oct; 63(10):1648-57. PubMed ID: 24225939
[TBL] [Abstract][Full Text] [Related]
51. Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection.
Jang JW; Yoo SH; Kwon JH; You CR; Lee S; Lee JH; Chung KW
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1337-46. PubMed ID: 22007836
[TBL] [Abstract][Full Text] [Related]
52. Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study.
Nakayoshi T; Maeshiro T; Nakayoshi T; Nakasone H; Sakugawa H; Kinjo F; Orito E; Mizokami M
J Med Virol; 2003 Jul; 70(3):350-4. PubMed ID: 12766996
[TBL] [Abstract][Full Text] [Related]
53. Independent risk factors for hepatocellular carcinoma in French drinkers.
Poynard T; Aubert A; Lazizi Y; Bedossa P; Hamelin B; Terris B; Naveau S; Dubreuil P; Pillot J; Chaput JC
Hepatology; 1991 May; 13(5):896-901. PubMed ID: 1851493
[TBL] [Abstract][Full Text] [Related]
54. [Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years].
Sun Y; Chen TY; Lu PX; Wang JB; Wu Y; Zhang QN; Qian GS; Tu H
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1874-7. PubMed ID: 23134955
[TBL] [Abstract][Full Text] [Related]
55. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
56. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
57. Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men.
Wu JF; Tsai WY; Hsu HY; Ni YH; Chen HL; Tsuei DJ; Chang MH
Gastroenterology; 2010 Mar; 138(3):942-8.e1. PubMed ID: 19962986
[TBL] [Abstract][Full Text] [Related]
58. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
[TBL] [Abstract][Full Text] [Related]
59. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
Liang TJ; Ghany M
N Engl J Med; 2002 Jul; 347(3):208-10. PubMed ID: 12124411
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
